BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27254276)

  • 1. Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor β.
    Park JW; Zhao L; Willingham MC; Cheng SY
    Mol Carcinog; 2017 Feb; 56(2):489-498. PubMed ID: 27254276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma.
    Lu C; Zhao L; Ying H; Willingham MC; Cheng SY
    Endocrinology; 2010 Apr; 151(4):1929-39. PubMed ID: 20133453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of beta-catenin by a novel nongenomic action of thyroid hormone beta receptor.
    Guigon CJ; Zhao L; Lu C; Willingham MC; Cheng SY
    Mol Cell Biol; 2008 Jul; 28(14):4598-608. PubMed ID: 18474620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tumor suppressor role for thyroid hormone beta receptor in a mouse model of thyroid carcinogenesis.
    Kato Y; Ying H; Willingham MC; Cheng SY
    Endocrinology; 2004 Oct; 145(10):4430-8. PubMed ID: 15231697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer.
    Guigon CJ; Zhao L; Willingham MC; Cheng SY
    Oncogene; 2009 Jan; 28(4):509-17. PubMed ID: 18997818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
    Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY
    Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel oncogenic actions of TRbeta mutants in tumorigenesis.
    Guigon CJ; Cheng SY
    IUBMB Life; 2009 May; 61(5):528-36. PubMed ID: 19391168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant accumulation of PTTG1 induced by a mutated thyroid hormone beta receptor inhibits mitotic progression.
    Ying H; Furuya F; Zhao L; Araki O; West BL; Hanover JA; Willingham MC; Cheng SY
    J Clin Invest; 2006 Nov; 116(11):2972-84. PubMed ID: 17039256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic signaling of KRAS and thyroid hormone receptor β mutants promotes undifferentiated thyroid cancer through MYC up-regulation.
    Zhu X; Zhao L; Park JW; Willingham MC; Cheng SY
    Neoplasia; 2014 Sep; 16(9):757-69. PubMed ID: 25246276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer.
    Furuya F; Lu C; Willingham MC; Cheng SY
    Carcinogenesis; 2007 Dec; 28(12):2451-8. PubMed ID: 17660507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tumorigenesis by the thyroid hormone receptor β in xenograft models.
    Kim WG; Zhao L; Kim DW; Willingham MC; Cheng SY
    Thyroid; 2014 Feb; 24(2):260-9. PubMed ID: 23731250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gelsolin: a novel thyroid hormone receptor-beta interacting protein that modulates tumor progression in a mouse model of follicular thyroid cancer.
    Kim CS; Furuya F; Ying H; Kato Y; Hanover JA; Cheng SY
    Endocrinology; 2007 Mar; 148(3):1306-12. PubMed ID: 17170101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model.
    Zhu X; Enomoto K; Zhao L; Zhu YJ; Willingham MC; Meltzer P; Qi J; Cheng SY
    Clin Cancer Res; 2017 Jan; 23(2):430-440. PubMed ID: 27440272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diet-induced obesity increases tumor growth and promotes anaplastic change in thyroid cancer in a mouse model.
    Kim WG; Park JW; Willingham MC; Cheng SY
    Endocrinology; 2013 Aug; 154(8):2936-47. PubMed ID: 23748362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid Cancer.
    Carr FE; Tai PW; Barnum MS; Gillis NE; Evans KG; Taber TH; White JH; Tomczak JA; Jaworski DM; Zaidi SK; Lian JB; Stein JL; Stein GS
    Endocrinology; 2016 Aug; 157(8):3278-92. PubMed ID: 27253998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Src-dependent phosphorylation at Y406 on the thyroid hormone receptor β confers the tumor suppressor activity.
    Park JW; Zhao L; Webb P; Cheng SY
    Oncotarget; 2014 Oct; 5(20):10002-16. PubMed ID: 25275301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The steroid receptor coactivator-3 is a tumor promoter in a mouse model of thyroid cancer.
    Ying H; Willingham MC; Cheng SY
    Oncogene; 2008 Jan; 27(6):823-30. PubMed ID: 17653082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer.
    Kim CS; Ying H; Willingham MC; Cheng SY
    Carcinogenesis; 2007 May; 28(5):932-9. PubMed ID: 17127711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common tumor-suppressive signaling of thyroid hormone receptor beta in breast and thyroid cancer cells.
    Bolf EL; Gillis NE; Davidson CD; Cozzens LM; Kogut S; Tomczak JA; Frietze S; Carr FE
    Mol Carcinog; 2021 Dec; 60(12):874-885. PubMed ID: 34534367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors.
    Guigon CJ; Kim DW; Willingham MC; Cheng SY
    Oncogene; 2011 Jul; 30(30):3381-90. PubMed ID: 21399657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.